Abstract
The document associated with this DOI has been withdrawn.
Highlights
Review of: "New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): review of the literature and single-center experience."
Potential competing interests: The author(s) declared that no potential competing interests exist. This is really an interesting observation and it holds a lot of future work in this direction
The authors have primarily looked at immunotherapeutic drugs but it would be interesting to look at other chemotherapeutic drugs which might be responsible for medication-related osteonecrosis of the jaw (MRONJ)
Summary
Review of: "New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): review of the literature and single-center experience."
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
